文献速递母胎医学

子宫肌瘤剔除术后胎盘植入谱系:按手术路径分层的系统综述与Meta分析

Placenta Accreta Spectrum After Myomectomy: A Systematic Review and Meta-Analysis Stratified by Surgical Approach.
PubMed 文献 · Am J Obstet Gynecol · 2026-02-05

结果显示子宫肌瘤剔除术后PAS总患病率为1%(95%CI,1-2%),开腹、腹腔镜、机器人及宫腔镜路径间差异无统计学意义(P=0.67)。产后出血、前置胎盘、胎盘早剥、子宫破裂等并发症在不同手术路径间也无显著差异。

要点

  • 子宫肌瘤剔除术后PAS总患病率约1%-2%,总体风险较低。
  • 开腹、腹腔镜、机器人、宫腔镜各路径间PAS风险无显著差异(P=0.67)。
  • 手术路径选择可依据患者特征、肌瘤特点及术者经验个体化决定。

核心结论

  • 子宫肌瘤剔除术后PAS总患病率约为1%-2%,不同手术路径间无显著差异(P=0.67)。
  • 产后出血、前置胎盘、胎盘早剥、子宫破裂等并发症在各手术路径间同样无显著差异。
  • 子宫肌瘤剔除术的手术路径可根据患者特征、肌瘤特点及术者经验进行个体化选择。

研究设计与样本

  • 系统综述与Meta分析,按PRISMA指南实施,注册于PROSPERO(CRD42024513596)。
  • 检索PubMed、Embase、Scopus和Web of Science,检索时间为建库至2025年3月。
  • 采用随机效应Meta分析计算合并患病率及95%CI,并用I²统计量评估异质性。

主要发现

  • PAS总合并患病率为1%(95%CI,1-2%)。
  • 开腹子宫肌瘤剔除术后PAS患病率为2%(95%CI,1-4%;111/4474)。
  • 腹腔镜子宫肌瘤剔除术后PAS患病率为1%(95%CI,0-3%;36/1172)。
  • 机器人子宫肌瘤剔除术后PAS患病率为1%(95%CI,0-4%;4/262)。
  • 宫腔镜子宫肌瘤剔除术后PAS患病率低于1%(95%CI,0-1%;3/271)。

关键数值与推荐

  • PAS总合并患病率:1%(95%CI,1-2%)。
  • 开腹路径PAS患病率:2%(95%CI,1-4%;111/4474)。
  • 腹腔镜路径PAS患病率:1%(95%CI,0-3%;36/1172)。
  • 机器人路径PAS患病率:1%(95%CI,0-4%;4/262)。
  • 宫腔镜路径PAS患病率:<1%(95%CI,0-1%;3/271)。

临床怎么用

  • 有子宫肌瘤剔除史的孕妇PAS总体风险约1%-2%,产前影像学监测可参考该风险水平。
  • 手术路径不显著影响后续妊娠PAS及主要产科并发症风险,路径选择可个体化。

局限性

  • 未对各手术路径组的肌瘤特征、患者基线特征及术者经验进行校正。
  • 各手术路径亚组的样本量和事件数分布不均,部分亚组事件数较少。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Placenta Accreta Spectrum (PAS) occurs in approximately 0.17% pregnancies in the general obstetric population. We aimed to estimate the prevalence of PAS following myomectomy surgery and evaluate differences in the risks by myomectomy surgical approach. DATA SOURCES: PubMed, Embase, Scopus, and Web of Science were searched on prespecified dates (inception-March 2025). STUDY ELIGIBILITY CRITERIA: Studies were eligible if they reported pregnancy outcomes in patients with a documented history of myomectomy in which the surgical approach was specified. STUDY APPRAISAL AND SYNTHESIS METHODS: This systematic review and meta-analysis was conducted per PRISMA guidelines and registered on PROSPERO (CRD42024513596). Pooled prevalence estimates and 95% confidence intervals (CIs) were calculated using random-effects meta-analysis. Planned subgroup analyses were conducted for myomectomy surgical approach and PAS-accompanying morbidities of postpartum hemorrhage, placenta previa, placental abruption, and uterine rupture, and heterogeneity was assessed using I2 statistics. RESULTS: Seventy-six studies comprising 11065 pregnancies across 24 countries were included. The pooled prevalence of PAS following myomectomy was 1% (95% CI, 1-2%). Prespecified subgroup analyses demonstrated that PAS prevalence was highest after open myomectomy (2%; 95% CI, 1-4%; 111/4474) compared to laparoscopic (1%; 95% CI, 0-3%; 36/1172), robotic (1%; 95% CI, 0-4%; 4/262), and hysteroscopic approaches (<1%; 95% CI, 0-1%; 3/271), although differences between surgical groups were not statistically significant (P = 0.67). Secondary outcomes-including postpartum hemorrhage (2%), placenta previa (1%), placental abruption (1%), and uterine rupture (<1%)-showed similar prevalence patterns across surgical approaches. CONCLUSIONS: In this meta-analysis of over 11,000 patients, the overall prevalence of PAS following myomectomy was approximately 1-2% and did not significantly differ by surgical approach. Likewise, major obstetric complications, including postpartum hemorrhage, placenta previa, and uterine rupture, showed no significant variations among open, laparoscopic, hysteroscopic, and robotic myomectomies. Therefore, the choice of surgical approach for myomectomy can be individualized based on patient characteristics, myoma features, and surgical expertise.

来源:Am J Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Rojhani, Abiad, Zargarzadeh, et al. Placenta Accreta Spectrum After Myomectomy: A Systematic Review and Meta-Analysis Stratified by Surgical Approach. Am J Obstet Gynecol. 2026. PMID: 41654249. doi:10.1016/j.ajog.2026.02.003

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。